Showing 121-130 of 455 results for "".
Comorbidities in Alopecia Areata
https://practicaldermatology.com/issues/july-2025/comorbidities-in-alopecia-areata/36507/Alopecia areata (AA) is a chronic, relapsing immune-mediated disorder that causes nonscarring hair loss that can significantly impact a patient’s quality of life.What About Diet? The Complex Relationship between Food and Atopic Dermatitis
https://practicaldermatology.com/columns/clinical-focus-1/what-about-diet-the-complex-relationship-between-food-and-atopic-dermatitis/23175/Exploring the clinical implications of our current understanding of diet and eczema.A Case of Pemphigus Foliaceus
https://practicaldermatology.com/topics/infections-infectious-disease/a-case-of-pemphigus-foliaceus/23156/A case-based discussion of an immunobullous disorder.BPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to DianLyme Disease Update
https://practicaldermatology.com/topics/general-topics/lyme-disease-update/20604/Exploring current thinking about Lyme Disease diagnosis and treatment.Topical CBD For Skincare: Key Considerations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/topical-cbd-for-skincare-key-considerations/23701/Topically applied CBD shows promise, but there is still a lot to learn.Advances in the Treatment of Reticular Erythematous Mucinosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/advances-in-the-treatment-of-reticular-erythematous-mucinosis/23491/Considering nicotinamide’s anti-inflammatory properties for inflammatory dermatological conditions to avoid steroid and antibiotic overuse.Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/annual-trends-in-medicare-part-d-prescription-claims-for-guselkumab-20182020/28861/Jachin Wu, MD, FAAD, and colleagues talk about Medicare claims for guselkumabIt is Time to Move Beyond Mushroom Tyrosinase. And Is Hydroquinone What We Think It Is?
https://practicaldermatology.com/topics/pigmentary-disorders/it-is-time-to-move-beyond-mushroom-tyrosinase-and-is-hydroquinone-what-we-think-it-is/23768/New research is offering better clinical clues about the action of tyrosinase inhibitors.Soliton’s RAP Technology for Cellulite
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/solitons-rap-technology-for-cellulite/23465/An inside look at the latest device designed to target cellulite.